Vitamin D type added for CYP24A1 vitamin D deficiency
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary clinical trials.
This study tests a vitamin D-like medicine for people with a specific genetic cause of low active vitamin D (CYP24A1 deficiency). If you have the right gene change, it may help your body use vitamin D more normally.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic test showing CYP24A1 has two changed copies (biallelic mutation)
- You are able to give informed consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests rifampin to improve high blood and/or urine calcium that happens in people with CYP24A1 gene changes. It also checks safety by watching liver and kidney blood tests and pregnancy status.
This is a research registry for people who have a confirmed CYP24A1 genetic change tied to high calcium and kidney stone problems. It helps researchers better understand who is affected and may guide future studies or care approaches.
This trial compares two types of vitamin D—one is plain vitamin D2, the other is vitamin D2 plus a more active form (calcitriol)—to see which works better for children with liver problems and low vitamin D levels.
This trial studies whether giving a higher dose of vitamin D3 helps children and teens with inflammatory bowel disease (Crohn’s or ulcerative colitis) who have low vitamin D levels. Participants are already on biologic medicines and will be treated while monitoring blood (and safety) related to vitamin D.
This trial looks at whether low vitamin D levels are linked to inflammatory bowel disease (Crohn's and ulcerative colitis). It may help understand the role of vitamin D in managing these conditions.
This trial is testing whether giving preterm babies (born at 24 to 32 weeks) a high, carefully monitored dose of vitamin D right after birth helps improve their health compared to standard care.
Hear when a new Idiopathic Infantile Hypercalcemia - Severe Form trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.